Analysis of the Chronic Hepatitis B Care Cascade and Treatment Rates at a Tertiary Medical Center in Southern California
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Kevin Pak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Brooke Army Medical Center, Fort Sam, Houston, Texas, USA. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Antiviral Agents. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Chronic hepatitis B (CHB) affects the lives of up to 1.89 million people in the United States. The aim of this study was to assess the CHB treatment rates at a tertiary medical system in Los Angeles. We conducted a retrospective analysis of all adult patients with CHB across the entire UCLA database from 2013 to 2023. Based on the ALT and HBV DNA, as well as diagnosis of cirrhosis by ICD‐9/10 codes, we determined the number of patients who were eligible for antiviral therapy per AASLD guidelines. Based on this information, we determined the treatment rate of CHB. In the study period, there were 3,384 patients with positive HBsAg. 511 of these patients had HBV‐related cirrhosis. Moreover, 429 of 511 cirrhotic patients were on therapy (84%). Of the 2873 non‐cirrhotic patients, only 51 patients met treatment criteria per AASLD guidelines. Of these patients, only 37 were started on therapy. However, a total of 1255 patients were on antiviral therapy (37.1%). In addition, 789 (23.3%) patients were on antiviral therapy who did not meet treatment criteria. From 2013 to 2023, the CHB care cascade at UCLA yielded a total treatment rate of 13.8%. Treatment rates of cirrhosis patients were much higher (84.0%). Significantly more patients than were otherwise eligible received treatment. This can potentially be explained by a considerable number of patients being started on treatment prior to being referred to and seen in the UCLA system and/or provider knowledge of treatment thresholds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Brooke Army Medical Center, Fort Sam, Houston, Texas, USA.
- Divsion of General Internal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
- Pfleger Liver Institute, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
ORCID-Profile: Kevin Pak
Zitieren
APA
Pak, K., Leng, M., & Han, S. B. (2026). Analysis of the Chronic Hepatitis B Care Cascade and Treatment Rates at a Tertiary Medical Center in Southern California. Journal of Medical Virology. https://doi.org/10.1002/jmv.70946
Vancouver
Pak K, Leng M, Han SB. Analysis of the Chronic Hepatitis B Care Cascade and Treatment Rates at a Tertiary Medical Center in Southern California. Journal of Medical Virology. 2026. doi:10.1002/jmv.70946
BibTeX
@article{Pak2026,
author = {Pak, Kevin and Leng, Mei and Han, Steven-Huy B},
title = {Analysis of the Chronic Hepatitis B Care Cascade and Treatment Rates at a Tertiary Medical Center in Southern California},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70946}
}
EUVIMED